These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20517537)

  • 1. Recent advances in the management of thyroid cancer and type 2 diabetes: highlights from the Annual Conference of the Society for Endocrinology (BES), March 15-18, 2010, Manchester, UK.
    Bandyopadhyay P
    Drugs Today (Barc); 2010 May; 46(5):361-7. PubMed ID: 20517537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid disorders: highlights from the Annual Conference of the Society for Endocrinology (BES).
    Bandyopadhyay P
    Drugs Today (Barc); 2008 Nov; 44(11):865-72. PubMed ID: 19180264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular diseases and diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2006; 19(6):369-75. PubMed ID: 16971974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2015 Annual Meeting of the Endocrine Society San Diego, CA (March 5-8, 2015) Selected Highlights.
    Hsu I; Burtman E; Ferris J; Austin J
    Pediatr Endocrinol Rev; 2015 Jun; 12(4):408-21. PubMed ID: 26182484
    [No Abstract]   [Full Text] [Related]  

  • 5. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
    Blonde L; Baker DE; Davis SN; Ratner RE
    J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of incretin-based therapies in the management of type 2 diabetes.
    Bandyopadhyay P
    Drug News Perspect; 2009 Nov; 22(9):559-67. PubMed ID: 20072733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present recommendations in type 2 diabetes treatment.
    Lebovitz HE
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():46-9. PubMed ID: 20629232
    [No Abstract]   [Full Text] [Related]  

  • 8. American Diabetes Association--70th scientific sessions--research on novel therapeutics: part 1.
    Croasdell G
    IDrugs; 2010 Sep; 13(9):595-7. PubMed ID: 20799136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Association for the Study of Diabetes Annual Meeting, 1998. Treatment of type 2 diabetes and the pathogenesis of complications.
    Bloomgarden ZT
    Diabetes Care; 1999 Jul; 22(7):1209-15. PubMed ID: 10388992
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2 diabetes mellitus: focus on new treatments and special populations.
    Del Prato S
    Int J Clin Pract Suppl; 2007 Aug; (154):1-2. PubMed ID: 17593271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thyroid dysfunction in patients with type 2 diabetes mellitus].
    Tereshchenko IV; Suslina AA
    Ter Arkh; 2014; 86(8):119-23. PubMed ID: 25306758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hypoglycemic agents in the management of non-insulin-dependent diabetes mellitus among the elderly.
    McAvoy KH
    Diabetes Educ; 1991; 17(5):411-3. PubMed ID: 1879284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the treatment of type II diabetes mellitus.
    Baliga BS; Fonseca VA
    Am Fam Physician; 1997 Feb; 55(3):817-24. PubMed ID: 9048504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Diabetes Association--70th scientific sessions--research on novel therapeutics: part 2.
    Croasdell G
    IDrugs; 2010 Sep; 13(9):598-600. PubMed ID: 20799137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?
    Kannan S; Nasr C
    Cleve Clin J Med; 2015 Mar; 82(3):142-4. PubMed ID: 25932736
    [No Abstract]   [Full Text] [Related]  

  • 16. New therapies for the management of type 2 diabetes.
    Barnett A
    Nurs Times; 2001 Feb 8-14; 97(6):34-6. PubMed ID: 11954247
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial watch: SGLT2 inhibitor shows promise in type 2 diabetes.
    Nat Rev Drug Discov; 2010 Mar; 9(3):182. PubMed ID: 20190779
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in diabetes care and management.
    Figge J; Figge HL
    Clin Orthop Relat Res; 1993 Nov; (296):31-6. PubMed ID: 8222444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential harms of type 2 diabetes drugs have been ignored, finds BMJ investigation.
    Kmietowicz Z
    BMJ; 2013 Jun; 346():f3782. PubMed ID: 23757752
    [No Abstract]   [Full Text] [Related]  

  • 20. Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.
    Parks M; Rosebraugh C
    N Engl J Med; 2010 Mar; 362(9):774-7. PubMed ID: 20164475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.